A Phase 1/2, Study Evaluating the Safety, Tolerability, PK, and Efficacy of Sotorasib (AMG 510) in Subjects With Solid Tumors With a Specific KRAS Mutation (CodeBreaK 100)
Amgen
Amgen
Amgen
Amgen
Amgen
Amgen
Amgen
Hoffmann-La Roche
Verastem, Inc.
Revolution Medicines, Inc.
Amgen
Amgen
Deciphera Pharmaceuticals, LLC
Amgen
Amgen
Vitrac Therapeutics, LLC
Allist Pharmaceuticals, Inc.